Duranti, S.; Pietragalla, A.; Daniele, G.; Nero, C.; Ciccarone, F.; Scambia, G.; Lorusso, D.
Role of Immune Checkpoint Inhibitors in Cervical Cancer: From Preclinical to Clinical Data. Cancers 2021, 13, 2089.
https://doi.org/10.3390/cancers13092089
AMA Style
Duranti S, Pietragalla A, Daniele G, Nero C, Ciccarone F, Scambia G, Lorusso D.
Role of Immune Checkpoint Inhibitors in Cervical Cancer: From Preclinical to Clinical Data. Cancers. 2021; 13(9):2089.
https://doi.org/10.3390/cancers13092089
Chicago/Turabian Style
Duranti, Simona, Antonella Pietragalla, Gennaro Daniele, Camilla Nero, Francesca Ciccarone, Giovanni Scambia, and Domenica Lorusso.
2021. "Role of Immune Checkpoint Inhibitors in Cervical Cancer: From Preclinical to Clinical Data" Cancers 13, no. 9: 2089.
https://doi.org/10.3390/cancers13092089
APA Style
Duranti, S., Pietragalla, A., Daniele, G., Nero, C., Ciccarone, F., Scambia, G., & Lorusso, D.
(2021). Role of Immune Checkpoint Inhibitors in Cervical Cancer: From Preclinical to Clinical Data. Cancers, 13(9), 2089.
https://doi.org/10.3390/cancers13092089